BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/21/2025 9:26:55 AM | Browse: 224 | Download: 901
Publication Name World Journal of Diabetes
Manuscript ID 102014
Country China
ISSN 1948-9358 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Urology & Nephrology
Manuscript Type Letter to the Editor
Article Title From metabolic regulation to kidney protection: β-arrestin 2 as a dual-function therapeutic target
Manuscript Source Invited Manuscript
All Author List Jian Yang, Cheng-Zhi Zhang and Jing Zhang
ORCID
Author(s) ORCID Number
Jian Yang http://orcid.org/0000-0002-1391-1482
Jing Zhang http://orcid.org/0009-0000-1410-0641
Funding Agency and Grant Number
Funding Agency Grant Number
National Natural Science Foundation of China 82471616, 82170418, 82271618
Natural Science Foundation of Hubei Province 2022CFA015
Central Guiding Local Science and Technology Development Project 2022BGE237
Key Research and Development Program of Hubei Province 2022BCE001, 2022DCC014, 2023BCB139
Hubei Provincial Health Commission Project WJ2023M151
Corresponding Author Jing Zhang, MD, Central Laboratory, The First College of Clinical Medical Science, China Three Gorges University & Yichang Central People’s Hospital, No. 183 Yiling Avenue, Yichang 443003, Hubei Province, China. zhangjing@ctgu.edu.cn
Key Words Type 2 diabetes; Diabetic nephropathy; Βeta-arrestin 2; Βeta-arrestin 1; Metabolic regulation; Tissue-specific signaling; Therapeutic strategies; Multi-target therapies
Core Tip This article highlights the dual-function potential of β-arrestin 2 as a therapeutic target for both diabetic nephropathy and metabolic regulation. Recent findings by Liu et al demonstrated that β-arrestin 2 exacerbates kidney damage in diabetic nephropathy by promoting glomerular endothelial cell apoptosis via the endoplasmic reticulum stress pathway. Conversely, β-arrestin 2 plays a significant role in regulating metabolic processes, such as hepatic glucose production, insulin secretion, and adipose tissue function. Its tissue-specific effects make β-arrestin 2 a promising target for therapeutic strategies, with ongoing advancements in biased ligands, small molecule modulators, and RNA aptamers.
Publish Date 2025-01-21 09:26
Citation

Yang J, Zhang CZ, Zhang J. From metabolic regulation to kidney protection: β-arrestin 2 as a dual-function therapeutic target. World J Diabetes 2025; 16(3): 102014

URL https://www.wjgnet.com/1948-9358/full/v16/i3/102014.htm
DOI https://dx.doi.org/10.4239/wjd.v16.i3.102014
Full Article (PDF) WJD-16-102014-with-cover.pdf